checkAd

     304  0 Kommentare Horizon Pharma plc Announces Settlement of RAYOS(R) (prednisone) Delayed-Release Tablets Patent Litigation With Actavis Laboratories FL Inc. - Seite 4

    Contacts:
    Investors:
    John Thomas
    Executive Vice President, Strategy and Investor Relations
    investor-relations@horizonpharma.com

    Tina Ventura
    Vice President, Investor Relations
    investor-relations@horizonpharma.com

    U.S. Media Contact:
    Geoff Curtis
    Group Vice President, Corporate Communications
    gcurtis@horizonpharma.com

    Ireland Media Contact:
    Ray Gordon
    Gordon MRM
    ray@gordonmrm.ie

    Lesen Sie auch

    Diskutieren Sie über die enthaltenen Werte


    Seite 4 von 4

    Verfasst von Marketwired
    6 im Artikel enthaltene WerteIm Artikel enthaltene Werte
    Horizon Pharma plc Announces Settlement of RAYOS(R) (prednisone) Delayed-Release Tablets Patent Litigation With Actavis Laboratories FL Inc. - Seite 4 DUBLIN, IRELAND--(Marketwired - Oct 2, 2015) - Horizon Pharma plc (NASDAQ: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines …